Skip to main content
Antioxidants logoLink to Antioxidants
. 2026 Jan 27;15(2):169. doi: 10.3390/antiox15020169

Bioactive Components of Parthenocissus quinquefolia with Antioxidant and Anti-Inflammatory Properties: A Systematic Review

Álvaro Becerra 1, Felipe Soto 1, Alejandro Vallejos 1, Daniela Millán 2, Juan José Valenzuela-Fuenzalida 3, Jose E Leon-Rojas 4,*, Manuel E Cortés 5
Editors: Rodrigo Iturriaga, Hugo Diaz
PMCID: PMC12937967  PMID: 41750550

Abstract

Background: Parthenocissus quinquefolia (Virginia creeper), widely distributed and used in Chile, lacks a systematic characterization of its bioactive components. This study synthesizes the evidence on the phytochemical composition and biological activities of P. quinquefolia, with emphasis on metabolites involved in redox regulation and inflammation. Methods: A systematic review was conducted following PRISMA 2020 guidelines. Searches were performed across four electronic databases, including original studies reporting antioxidant and anti-inflammatory effects. Results: Of 665 records identified, 14 studies met the inclusion criteria. Phytochemical analyses revealed phenolic compounds, particularly flavonoids (e.g., catechin, epicatechin, gallocatechin, epigallocatechin, quercetin, rutin, isoquercitrin, myricetin, luteolin, naringin) and stilbenes (e.g., ε-viniferin, miyabenol C). These metabolites exhibit antioxidant activity through ROS scavenging, metal chelation, and Nrf2/ARE activation. Anti-inflammatory effects were attributed to the downregulation of NF-κB, AP-1, and MAPK signaling, inhibition of NLRP3 inflammasome activation, and suppression of COX-2/iNOS expression. Conclusions: P. quinquefolia is a rich source of phenolic metabolites with robust antioxidant and anti-inflammatory mechanisms. The consistency of molecular responses across studies highlights its potential as a promising candidate for phytotherapeutic development targeting oxidative stress and inflammatory pathways.

Keywords: Nrf2/ARE pathway, NF-κB signaling, secondary metabolites, phenolic profile, phytochemical analysis, bioactive compounds, Vitaceae family

1. Introduction

Parthenocissus quinquefolia (L.) Planch., commonly known as Virginia creeper, is a member of the Vitaceae family and is indigenous to North America; however, it is now cultivated and distributed worldwide, including in Chile through horticultural nurseries and ornamental landscaping projects [1,2]. Although P. quinquefolia is exotic to the Southern Cone, recent interest in introduced ornamental and medicinal plants in Chile alongside ongoing research into native species with antioxidant potential (e.g., Aristotelia chilensis, Berberis microphylla, Peumus boldus) [3,4] suggests that P. quinquefolia may represent a complementary phytochemical resource. Its local availability further enhances its potential for phytochemical research and future biotechnological applications. Historically, P. quinquefolia has been used by Native American populations for a wide range of medicinal purposes, including treatments for inflammatory conditions, metabolic disorders, and infectious processes [5]. More recently, experimental studies have reported antioxidant, anti-inflammatory, metabolic, antimicrobial, and anticancer properties associated with extracts obtained from different plant organs [6,7,8,9,10,11]. Collectively, these findings suggest potential protective effects against cancer progression, as well as antibacterial, antiviral, antidiabetic, antirheumatic, hypocholesterolemic, gastrointestinal, and diuretic activities. Collectively, these findings suggest potential protective effects against cancer progression, as well as antibacterial, antiviral, antidiabetic, antirheumatic, hypocholesterolemic, gastrointestinal, and diuretic activities. These biological properties are largely attributed to the presence of secondary metabolites bioactive compounds synthesized by plants in response to biotic and abiotic stimuli, enabling adaptation to environmental stressors [12]. These compounds are widely utilized in the pharmaceutical, cosmetic, nutraceutical, food, and agrochemical industries [13,14,15]. Consequently, the ethnobotanical and pharmacological characterization of introduced and native species has become increasingly relevant for identifying compounds with biomedical applications.

Given that many of these biological activities are mechanistically linked to redox imbalance and immune modulation, it is pertinent to consider the role of inflammation in this context. Inflammation represents a complex biological response to cellular and tissue injury caused by pathogens (e.g., viruses, bacteria, fungi), chemical irritants, physical agents, or dysregulated immune activity. When unresolved, inflammation may become chronic, promoting oxidative stress, cellular damage, and molecular remodeling associated with carcinogenesis, accelerated aging, metabolic disease, and increased mortality [16,17]. Considerable evidence has demonstrated that secondary metabolites exert antioxidant and anti-inflammatory effects through redox modulation, reactive oxygen species (ROS) scavenging, mitochondrial protection, and regulation of pro-inflammatory signaling pathways such as NF-κB, COX-2, and iNOS [18,19,20,21]. The abundance of phenolic compounds with antioxidant and anti-inflammatory properties reported in P. quinquefolia suggests that this species may contribute to the identification of novel therapeutic targets. Therefore, the objective of this systematic review is to summarize the available evidence regarding the composition, distribution, and biological effects of secondary metabolites with anti-inflammatory potential isolated from or identified in P. quinquefolia.

The abundance of compounds with antioxidant and anti-inflammatory properties in P. quinquefolia suggest its potential for the identification of novel therapeutic targets. The objective of this review is to provide an overview of the reported composition, distribution, and biological effects of secondary metabolites with anti-inflammatory properties in P. quinquefolia.

Representative structures of phenolic metabolites identified in P. quinquefolia are shown in Figure 1 to illustrate the chemical diversity of flavonoids and stilbenoids present in the species.

Figure 1.

Figure 1

Chemical structures of key phenolic metabolites identified in Parthenocissus quinquefolia. (A) Quercetin, (B) Rutin, (C) ε-Viniferin.

2. Materials and Methods

2.1. Method Designs

This study was guided by the checklist of proposed elements according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 [22]. The registration DOI in Open Science Framework (OSF) is https://osf.io/hx8nw (Accessed 4 January 2026).

2.2. Selection Criteria

Studies eligible for inclusion are original research articles that provide information on the anti-inflammatory or antioxidant effects, as well as other beneficial health effects, of the plant species P. quinquefolia, or any of its other names mentioned in the search terms (Ampelopsis quinquefolia, Hedera quinquefolia, Vitis quinquefolia, Virginia creeper), published in English.

2.3. Information Source and Search Strategies

A systematic search was conducted in PubMed, Scopus, Web of Science, and Google Scholar from inception to May 2025. Additional records were identified through reference screening. No publication date restrictions were applied. Language was restricted to English and only original research articles were eligible. The following Boolean search strategy was used: (“Parthenocissus quinquefolia” OR “Ampelopsis quinquefolia” OR “Hedera quinquefolia” OR “Vitis quinquefolia” OR “Virginia creeper”) AND (“antioxidant” OR “anti-inflammatory” OR “bioactive” OR “phytochemical” OR “stilbene” OR “phenolic” OR “flavonoid”). Database-specific search strings are provided in Supplementary Material (Table S1), in-cluding search dates, Boolean operators, and applied filters.

2.4. Study Selection

All records identified through database searching were imported into a reference manager and duplicates were removed. The screening process followed the PRISMA 2020 recommendations and was conducted in two stages. In the first stage, two reviewers independently screened titles and abstracts. Records were excluded at this stage if they met any of the following criteria: (1) non-original publications (e.g., reviews, conference abstracts, book chapters), (2) studies not focusing on Parthenocissus quinquefolia, or (3) absence of biological, phytochemical, antioxidant, or anti-inflammatory outcomes. Full-text articles were then retrieved for all records that passed the initial screening. In the second stage, the same reviewers independently assessed full-text eligibility. Full-text exclusions were applied for the following reasons: (1) full text not accessible, (2) language not meeting inclusion criteria, (3) absence of relevant biological outcomes, or (4) unclear plant identification. Discrepancies at any screening stage were resolved by discussion and consensus. No automation tools were used during the selection process.

2.5. Methodological Quality Assessment

Because the included evidence consisted of phytochemical characterizations and non-clinical experimental studies (in vitro/in vivo), traditional clinical risk of bias tools (e.g., RoB 2, ROBINS-I) were not applicable. Instead, methodological quality was assessed using criteria adapted for non-clinical research, including: (1) botanical identification, (2) extraction reporting, (3) analytical validation, (4) use of controls in bioassays, and (5) replication reporting. Two reviewers independently assessed methodological quality, and disagreements were resolved by consensus.

3. Results

A total of 665 records were identified through database searching, and an additional 2 records were identified through other sources. Before screening, 26 records were removed. A total of 639 records were screened at the title and abstract level, resulting in the exclusion of 349 records for not meeting the inclusion criteria. Full texts were sought for 290 records, of which 177 could not be retrieved. The remaining 113 full-text reports were assessed for eligibility. Of these, 99 were excluded due to being case reports, letters to the editor, presenting irrelevant data, or being published in a non-eligible language. In parallel, two additional reports identified through other sources were assessed, both of which were excluded for the same reasons. Ultimately, 14 studies met the inclusion criteria and were incorporated into the systematic review. The updated PRISMA 2020 flow diagram is shown in Figure 2. All included studies were written in English and consisted exclusively of laboratory work without human or animal intervention. The studies originated from a broad geographical distribution, including Pakistan (n = 2), Ukraine (n = 2), and one study each from Japan, China, Thailand, Tunisia, India, Iran, Turkey, the United States, Hungary, and Saudi Arabia. The included research focused on phytochemical analyses and non-clinical assays performed on different plant parts of P. quinquefolia, including leaves, fruits, stems, and shoots. Analytical approaches varied, encompassing colorimetric assays, chromatographic profiling (e.g., HPLC, HPLC-MS), and spectrophotometric quantification. Experimental models included antioxidant capacity assays (e.g., DPPH, ABTS, FRAP) and other non-interventional in vitro assays. The main characteristics of the included studies are summarized in Table 1.

Figure 2.

Figure 2

PRISMA 2020 flow diagram illustrating the selection of studies included in the review. Adapted from Page et al. (2021) [22].

Table 1.

General characteristics of each selected study (n = 14).

Study Plant Part Used Extraction Method Analytical Technique Identified Compounds Concentrations Assay Conditions/Biological Assays
Tanaka T., Inuma M. Murata H. (1998) [23] Stems Acetone + Methanol extracts Phytochemistry/Chromatography Parthenocissin A, Parthenocissin B Not reported Antioxidant activity (in vitro), qualitative
Kumar S. et al. (2011) [9] Not specified Not reported Not reported Not reported 250 mg/kg p.c. (oral) Antidiabetic activity in Zucker rats
Yang J. et al. (2013) [24] Stems Ethanol extract HPLC/Chromatography Parthenocissin M, Parthenocissin N, Miyabenol C, ε-viniferin Not reported Hepatoprotective, antibacterial, antifungal assays (in vitro)
Rattanata N. et al. (2014) [25] Leaves Ethanol extract Colorimetric assays Total phenolics, flavonoids (non-specific) TPC/FC values not stated in manuscript Antioxidant (DPPH, ABTS), Antibacterial assays
Zardi-Bergaoui A. et al. (2016) [6] Pods & seeds Soxhlet extraction (hexane) GC-MS Linoleic acid, Palmitic acid, Oleic acid % composition reported in original study (not provided in manuscript) Antioxidant/Antiradical activity
Deshmukh-Omraj S. (2017) [26] Roots Crude extract Qualitative phytochemical screening Alkaloids, Flavonoids, Terpenoids, Steroids, Coumarins, Carbohydrates, Tannins Not applicable (qualitative) Antibacterial assays (in vitro)
Zaheer-Ud-Din K. et al. (2017) [7] Leaves & fruits Crude ethanolic extracts Qualitative phytochemical screening Terpenoids, Flavonoids, Saponins, Tannins, Alkaloids, Glycosides Not applicable (qualitative) Antioxidant assays (DPPH)
Faisal S. et al. (2018) [10] Bark Methanolic extract Colorimetric assays Total phenolics TPC value not provided in manuscript Free radical scavenging assays
Mohamed A. A. et al. (2021) [27] Fruits Ethanolic extract HPLC Rutin, Myricetin Rutin: 1891.60 mg/100 g extract; Myricetin: 241.06 mg/100 g extract Antimicrobial and fungicidal assays
Ticha et al. (2017) [28] Fruits Ultrasonic aqueous extraction HPLC-MS Anthocyanins: delphinidin, petunidin, cyanidin, malvidin, peonidin, pelargonidin Not reported No biological assays performed (phytodyeing application)
Makhynia L., Yemelianova O. (2023) [29] Leaves (flowering & fruiting stages) Not reported Qualitative phytochemical screening Phenols, Flavonoids, Polysaccharides, Saponins, Tannins, Catechins, Anthocyanins, Hydroxycinnamic acids Not applicable No biological assays performed
Konovalova O. et al. (2023) [30] Leaves, shoots, fruits Ethanol extract HPLC Rutin, Quercetin, Quercetin-3-β-glycoside, Naringin (leaves & shoots); Epicatechin, Catechin, Gallocatechin, Epicatechin gallate, Luteolin (fruit) Not reported Antioxidant assays (DPPH)
Rónavári A. et al. (2023) [31] Leaves Green extract for nanoparticle synthesis HPLC (phenolics), LC-analysis Total phenolics, sugars (fructose, glucose, sucrose, mannitol, citric acid) Not reported No biological assays performed
Önder FC. et al. (2024) [11] Fruits & red leaves Ethanol extract HPLC Total phenolic content (non-specific) TPC reported in original study (not in manuscript) Anticancer, Antioxidant, Antimicrobial assays

The included studies focused on extracting and determining the chemical composition of different parts of P. quinquefolia, as well as their possible biological effects. Based on the extracted information, the properties of the species were categorized according to: (i) the plant parts used (stems, leaves, fruits, shoots), (ii) the type of extracts obtained, and (iii) the biological effects evaluated by the authors. These categories are summarized in Table 2.

Table 2.

Phytochemical and bioactivity characteristics specific to each selected study.

Study Plant Part Identified Compounds Quantification Bioassay Type Biological Effect
Tanaka T. Inuma M., Murata H. (1998) [23] Stems Parthenocissins A, B Not reported (structural identification only) Antioxidant (in vitro) Positive antioxidant activity
Kumar S. et al. (2011) [9] Not specified Not reported Not reported In vivo (Zucker diabetic rat model; Oral glucose tolerance; Insulin ELISA) Positive antihyperglycemic effect
Yang J. et al. (2013) [24] Stems Parthenocissins M/N, Miyabenol C, ε-viniferin Not reported Chemopreventive, antibacterial, antifungal Positive effects reported
Rattanata N. et al. (2014) [25] Leaves Total phenolics/flavonoids (nonspecific) TPC/TFC not reported Antioxidant (DPPH, ABTS), antibacterial Positive activity
Zardi-Bergaoui A. et al. (2016) [6] Pods and seeds Linoleic, palmitic, oleic acids inhibition DPPH 31.6–83.8% Antioxidant/antiradical Positive activity
Deshmukh-Omraj S. (2017) [26] Roots Various phytochemicals (qualitative) Not applicable (qualitative) Antibacterial Positive activity
Ud-Din Khan Z. et al. (2017) [7] Leaves & fruits Terpenoids, flavonoids, etc. (qualitative) Not applicable (qualitative) Antioxidant (DPPH) Positive activity
Faisal S. et al. (2018) [10] Bark Total phenolics IC50 bark ~24.32 mg/mL; stem ~13.6 mg/mL Antioxidant Positive scavenging activity
Mohamed A. A. et al. (2021) [27] Fruits Rutin, Myricetin Not reported Antimicrobial/fungicidal Positive activity
Ticha et al. (2017) [28] Fruits Anthocyanins (delphinidin, petunidin, cyanidin, etc.) Not reported Not evaluated No bioactivity reported
Makhynia L., Yemelianova O. (2023) [29] Leaves (2 stages) Phenolics, flavonoids, etc. (qualitative) Not applicable (qualitative) Not evaluated No bioactivity reported
Konovalova O. et al. (2023) [30] Leaves/shoots/fruits Rutin, quercetin, catechins, etc. Not reported Antioxidant (DPPH) Positive activity
Rónavári A. et al. (2023) [31] Leaves Total phenolics & sugars Not reported Not evaluated No bioactivity reported
Cömert Önder F. et al. (2024) [11] Fruits & red leaves Total phenolics TPC reported in original study (Not in manuscript) Anticancer, antioxidant, antimicrobial Positive activity

4. Discussion

4.1. Phytochemical Profile of Parthenocissus quinquefolia

Available evidence indicates that P. quinquefolia contains a diverse spectrum of phenolic secondary metabolites, particularly flavonoids and stilbenoids, which represent the most consistently reported bioactive constituents of the species (Table 2). Phenolic compounds are biosynthesized through the phenylpropanoid pathway and are characterized by at least one aromatic ring bearing hydroxyl substituents. Structurally, they encompass several subclasses, of which flavonoids and stilbenes are the most relevant in P. quinquefolia due to their antioxidant and anti-inflammatory potential [32,33,34,35,36,37,38].

4.1.1. Flavonoids

Flavonoids are low-molecular-weight polyphenols defined by a C6–C3–C6 backbone. In P. quinquefolia, flavonoids reported include flavonols (e.g., quercetin and glycosylated derivatives) and flavan-3-ols (e.g., catechin and epicatechin), mostly detected in leaves, shoots and fruits. These compounds have been associated with radical-scavenging activity, metal chelation, and modulation of redox-sensitive signaling pathways such as NF-κB and Nrf2/ARE in broader pharmacological literature, providing mechanistic plausibility for the antioxidant and anti-inflammatory effects observed in the plant.

Among detected flavonols, quercetin and rutin are particularly relevant. Quercetin has been widely characterized as an antioxidant through direct ROS scavenging as well as activation of endogenous enzymatic defenses via Nrf2, whereas glycosylated forms such as rutin display enhanced stability and documented anti-inflammatory effects via NF-κB inhibition [39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57]. Although these mechanistic properties have been largely demonstrated in non-Parthenocissus systems, their presence in P. quinquefolia suggests functional relevance within its phytochemical matrix.

Flavan-3-ols such as catechin and epicatechin have also been reported. These compounds possess catechol-type moieties that enhance redox activity and exhibit documented interactions with endothelial nitric oxide synthase and pro-inflammatory cytokine signaling, supporting a role in vascular redox modulation [58,59,60,61,62,63,64,65,66,67,68,69,70]. Their occurrence in P. quinquefolia aligns with the polyphenolic profiles documented in other Vitaceae.

4.1.2. Stilbenoids

Stilbenes constitute another major phenolic class in P. quinquefolia. The species contains resveratrol and a range of resveratrol-derived oligomers (e.g., parthenocissins and ε-viniferin), expanding its stilbenoid repertoire beyond that of many related taxa [24,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92]. Structural oligomerization enhances π-electron delocalization and increases the number of accessible phenolic hydroxyl groups, properties associated with superior radical-scavenging and anti-inflammatory capacity relative to monomeric resveratrol [93,94,95,96,97,98,99,100,101,102,103,104,105].

Notably, parthenocissin-type oligomers have been isolated from the genus Parthenocissus, including dimers and higher-order oligomers. Although their functional characterization remains limited in P. quinquefolia, studies from other Vitaceae demonstrate inhibition of NF-κB and COX-2/iNOS expression by related oligomers such as ε-viniferin, supporting mechanistic plausibility for anti-inflammatory effects [106,107,108,109,110,111,112,113,114,115,116,117,118].

Among the studies included, antioxidant activity was evaluated exclusively through chemical in vitro assays, mainly DPPH, ABTS and FRAP, demonstrating relevant radical-scavenging and reducing capacity of extracts from leaves, shoots and fruits. However, no studies were found assessing antioxidant effects in cell-based models, animal models or clinical settings, and no biomarker-based evaluations (e.g., lipid peroxidation, protein oxidation, antioxidant enzymes) have been reported to date for P. quinquefolia. This gap prevents extrapolation of the in vitro antioxidant findings to physiological or therapeutic contexts and highlights the need for validation in biological systems. The findings of this review support that P. quinquefolia represents a relevant source of phenolic metabolites, in particular flavonoids and stilbenoids, capable of modulating central redox-inflammatory pathways such as NF-κB, COX-2/iNOS and the generation of PGE2/NO. This body of evidence provides biological plausibility to the antioxidant and anti-inflammatory effects attributed to the species. The most direct phytochemical and functional information derive from the studies on leaves, shoots and fruits, where flavones, flavonols and catechins (i.e., quercetin, quercetin-3-β-glucoside, rutin, catechin and epicatechin) have been identified and quantified, together with antioxidant activity evaluated by chemical assays. Taken together, this background confirms that the species harbors a complex polyphenolic matrix with significant bioactive potential (Figure 3 and Figure 4) [24,31].

Figure 3.

Figure 3

Proposed mechanism for antioxidant activation through the Nrf2/ARE pathway by phenolic metabolites identified in Parthenocissus quinquefolia. Phenolic compounds such as quercetin and myricetin promote Nrf2 nuclear translocation and induction of antioxidant enzymes (e.g., HO-1, SOD, CAT), contributing to redox homeostasis.

Figure 4.

Figure 4

Proposed mechanism for anti-inflammatory modulation through NF-κB inhibition by phenolic metabolites identified in Parthenocissus quinquefolia. Compounds including catechins, rutin and ε-viniferin reduce IκBα degradation and NF-κB nuclear translocation, downregulating COX-2, iNOS and pro-inflammatory cytokines.

A noteworthy aspect is the identification of resveratrol in P. quinquefolia [119], together with novel resveratrol oligomers, such as parthenocissin M and N [18]. These findings expand the stilbenoid repertoire of the species and suggest that part of its biological activity could be attributed to these higher-order assemblages. These oligomers exhibit distinct biological profiles compared to the monomer [24,120]. From a mechanistic perspective, the Vitaceae literature provides elements that enable the formulation of reasonable hypotheses without undue extrapolation. For example, in Vitis heyneana the trans-ε-viniferin dimer has been shown to suppress NF-κB activation and reduce COX-2/iNOS expression, thereby decreasing the dose-dependent production of PGE2 and NO in LPS-stimulated RAW 264.7 macrophages [118]. Given that P. quinquefolia contains stilbenoids and shares biosynthetic pathways with Vitis, including the production of viniferins and miyabenols [24,120,121], it is plausible that analogous oligomers present in this species contribute to anti-inflammatory effects through convergent molecular targets. In this context, the trimer miyabenol C, isolated and characterized in different Vitaceae [24,121,122], has been associated with neuroprotective effects involving β-secretase inhibition and β-amyloid reduction, indicating a functional spectrum that goes beyond redox modulation and reaches key proteases in amyloidogenesis [123]. Although these results derive from studies on Vitis thunbergii var. taiwaniana [123], they reinforce the idea that resveratrol oligomers may exhibit bioactivities superior or complementary to those of the monomer and may contribute to part of the effects reported in P. quinquefolia. With respect to flavonoids, the compounds detected in P. quinquefolia, such as rutin, quercetin and its glycosides (e.g., quercetin-3-O-alpha-L-rhamnoside) [119], catechin, epicatechin, and luteolin in the fruits, are supported by substantial mechanistic evidence. Quercetin and its glycosylated derivatives modulate the Nrf2/ARE pathway and repress NF-κB activation, reducing the expression of pro-inflammatory cytokines and COX-2, while strengthening enzymatic antioxidant defenses [124]. Recent advances in the broader pharmacological literature further expand the biological relevance of quercetin beyond its antioxidant and anti-inflammatory roles. A narrative review published in Nutrients (2025) highlights quercetin as a bioactive compound involved in women’s reproductive health, reporting modulatory effects on hormonal balance, fertility parameters, and gynecological disorders such as polycystic ovary syndrome, recurrent miscarriage, and endometrial cancer [125,126,127,128,129,130,131,132,133,134,135]. The authors describe molecular pathways through which quercetin may exert such effects, including PI3K/AKT, Nrf2, NF-κB, and other hormone-regulated signaling cascades, underscoring its ability to influence oxidative stress, inflammation, and endocrine regulation in reproductive tissues. These findings reinforce the broader pharmacological potential of quercetin as a principal phenolic constituent of P. quinquefolia, suggesting that its relevance may extend into reproductive and metabolic domains, although these hypotheses remain speculative until directly validated in this species. On the other hand, catechin and epicatechin, present in various Vitaceae species, exert antioxidant effects through direct redox activity and metal chelation and attenuate inflammation associated with oxidative stress and lipotoxic processes in cell and animal models [125]. In addition, kaempferol, identified in Parthenocissus species (specifically P. tricuspidata) [126], and widely distributed within the Vitaceae family, exhibits radical scavenging activity and modulates inflammatory pathways by inhibiting NF-κB and reducing mediators such as iNOS and COX-2 [127]. Taken together, this evidence suggests that the antioxidant and anti-inflammatory effects observed in P. quinquefolia may derive from the combined action of these flavonols, in interaction with catechins, on convergent molecular networks related to oxidative stress and inflammatory signaling. However, the specific participation of Nrf2 and the possible synergies between these compounds need to be evaluated directly in this species.

Beyond the polyphenolic profile of the photosynthetic organs, the biology of the tendrils and adhesion disks provides a distinctive chemical and structural component whose phytochemistry remains practically unexplored. Tendrils, described in Vitaceae for more than three centuries [128], are flexible, branched structures that, in species such as P. quinquefolia, develop expanded adhesive disks at the apexes, allowing attachment to the substrate by flattening and secreting mucilage [129,130]. In this species, adhesion does not depend on the coil, but on an adhesive composed of branched rhamnogalacturonan I, callose and mucilaginous pectins [131]. The formation of the disks involves the accumulation of mucilage, adjustment to the microrelief of the support, and subsequent lignification, which confers high environmental resistance [132]. Although tendrils are recognized as structures with medicinal value in several Vitaceae [133], to the best of our knowledge, there are no studies evaluating the bioactive properties of adhesive disks. This knowledge gap points to a concrete opportunity to investigate the relationship between its specialized polysaccharide composition and potential anti-inflammatory or antioxidant applications in Parthenocissus. Considering the range of antioxidant, anti-inflammatory and, in some cases, neuroprotective activities described for the flavonoids and stilbenoids present in P. quinquefolia, as well as the structural and polysaccharide properties of its tendrils and adhesive disks, the species emerges as a promising candidate for the development of standardized extracts, nutraceutical supplements and possible drugs derived from natural products. The combination of phenolic compounds, with extensive mechanistic support, and less-studied oligomeric metabolites suggests a synergistic potential that could be exploited in both anti-inflammatory interventions and strategies aimed at controlling oxidative stress or protecting tissues. However, moving towards biomedical applications requires validating the safety, bioavailability and in vivo efficacy of these compounds and their mixtures, as well as deepening the characterization of metabolites typical of specialized structures such as adhesion disks. The interpretation of the present findings requires consideration of biogeographical factors. All included studies were conducted on specimens collected in the Northern Hemisphere, where climatic conditions, photoperiod, temperature gradients and soil composition differ substantially from those in Chile. It is well-established that secondary metabolite biosynthesis in plants is modulated by environmental parameters such as UV exposure, temperature, water availability, altitude and soil nutrients, which may influence both the qualitative and quantitative profiles of phenolic compounds. Therefore, it is plausible that specimens of P. quinquefolia growing in Chile could exhibit distinct phenolic fingerprints either in relative abundance or in the presence of specific metabolites when compared to those reported in the literature. Comparative metabolomic studies would be required to confirm whether the stilbenoid and flavonoid profiles described in Northern Hemisphere populations are conserved under Chilean ecological conditions. In the Chilean context, a Mediterranean hotspot highly vulnerable to climate change and environmental oxidative stress, the characterization of antioxidant compounds from P. quinquefolia gains additional relevance [134,135]. Moreover, the widespread use of this species in nature-based solutions, especially in Mediterranean-type climates such as Chile, underscores the importance of understanding its phytochemical composition to more accurately assess its biological value and potential functional applications.

4.2. Limitations

Several methodological limitations should be considered when interpreting the findings of this review. First, the primary studies exhibited substantial heterogeneity in extraction procedures (e.g., solvent polarity, extraction temperature, ultrasound-assisted extraction), plant material selection (leaves, stems, fruits, roots), and phytochemical processing, all of which influence metabolite yield and composition. Second, analytical approaches varied across studies, ranging from qualitative phytochemical screening to quantitative chromatographic techniques (e.g., HPLC, HPLC-MS, GC-MS), limiting comparability of reported metabolite profiles. Third, biological assays used to assess antioxidant and anti-inflammatory activity were not standardized, with studies employing diverse in vitro systems (e.g., DPPH, ABTS, FRAP, NO scavenging, COX-2/iNOS expression assays), preventing direct aggregation of results. Fourth, the absence of in vivo or clinical studies restricts the translational interpretation of the reported bioactivities. Finally, the review design itself was limited by the lack of meta-analytic synthesis due to insufficiently homogeneous data and by the possibility of publication bias toward positive findings. Taken together, these factors warrant cautious interpretation and highlight the need for standardized, mechanistic, and in vivo investigations.

5. Conclusions

In conclusion, available evidence suggests that P. quinquefolia is a notable source of secondary metabolites (particularly polyphenols, flavonoids, and stilbenoids) with documented chemoprotective, antioxidant, and anti-inflammatory activities. These properties underscore its value not only as an ornamental or ethnobotanical species but also as a promising model for contemporary biomedical research. The polyphenols characterized in the species, including catechin, epicatechin, quercetin, myricetin, resveratrol and several resveratrol-derived oligomers (parthenocissins), act on central molecular pathways such as NF-κB, NLRP3, MAPKs, eNOS and Nrf2, thereby modulating oxidative stress and chronic inflammatory responses; processes implicated in cardiovascular, metabolic and neurodegenerative diseases, as well as in oncogenesis and aging. Although the existing body of literature (14 studies) is primarily based on in vitro assays and still lacks validation in animal models or clinical settings, the findings collectively suggest that P. quinquefolia is a credible natural source for the development of extracts, nutraceutical formulations, and lead compounds for drug discovery. Advancing towards translational applications will require rigorous studies addressing bioavailability, safety and in vivo efficacy to substantiate its therapeutic potential in conditions driven by oxidative stress and inflammation.

Abbreviations

PRISMA Preferred reporting items for systematic reviews and meta-analyses
OSF Open science framework
PCs Phenolic compounds
N Nitrogen
S Sulphur
ROS Reactive oxygen species
NF-κB Nuclear factor kappa B
NO Nitric oxide
eNOS Endothelial nitric oxide synthase
TGF-β Transforming growth factor-beta
LPS Lipopolysaccharide
TNFα Tumor necrosis factor-alpha
CRP C-reactive protein
SAA Serum amyloid A
ORAC Oxygen radical absorbance capacity
AP-1 Activator protein 1
MCP-1 Monocyte chemotactic protein 1
MMP-2 Matrix metalloproteinase-2
NLRP3 NOD-like receptor heat domain-associated protein 3
IL Interleukin
ATP Adenosine triphosphate
iNOS Inducible nitric oxide synthase
COX Cyclooxygenase
RNS Reactive nitrogen species
SOD Superoxide dismutase
CAT Catalase
Nrf2 Nuclear factor erythroid 2-related factor 2
HIV Human immunodeficiency virus
HBV Hepatitis B virus
HSV Herpes simplex virus
LDL Low-density lipoprotein
NASH Non-alcoholic steatohepatitis
MAPKs Mitogen-activated protein kinas
RCS Reactive chlorine species
HO-1 Heme oxygenase-1
PPARγ Peroxisome proliferator-activated receptor gamma
SIRT1 Sirtuin-1
PGE2 Prostaglandin E2
CLA Conjugated linoleic acid
ARE Antioxidant response element

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/antiox15020169/s1.

Author Contributions

Conceptualization, Á.B.; methodology, Á.B. and F.S.; software, F.S.; validation, Á.B., D.M. and J.J.V.-F.; formal analysis, Á.B., F.S., D.M. and M.E.C.; investigation, Á.B., F.S., D.M., A.V. and M.E.C.; resources, D.M. and J.E.L.-R.; data curation, F.S. and Á.B.; writing—drafting the original manuscript, Á.B., F.S. and M.E.C.; writing: review and editing, Á.B., F.S., D.M. and J.J.V.-F.; visualization, Á.B. and M.E.C. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing does not apply to this article.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

This research received no external funding.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Blinkova O., Makarenko N., Raichuk L., Havrylnuk Y., Grabovska T., Roubik H. Invasion of Parthenocissus quinquefolia (L.) Planch in the forest-steppe of Ukraine. Ecol. Quest. 2022;34:35–44. doi: 10.12775/EQ.2023.011. [DOI] [Google Scholar]
  • 2.Colasoanto M. Fire Effects Information System. USDA; Washington, DC, USA: 1991. [(accessed on 22 April 2025)]. Parthenocissus quinquefolia. Available online: https://www.fdacs.gov/Agriculture-Industry/Plants-and-Nurseries. [Google Scholar]
  • 3.Salehi B., Sharifi-Rad J., Herrera-Bravo J., Salazar L.A., Delporte C., Barra G.V., Cazar Ramirez M.E., López M.D., Ramírez-Alarcón K., Cruz-Martins N., et al. Ethnopharmacology, Phytochemistry and Biological Activities of Native Chilean Plants. Curr. Pharm. Des. 2021;27:953–970. doi: 10.2174/1381612826666201124105623. [DOI] [PubMed] [Google Scholar]
  • 4.Alfaro S. Antioxidant activity and phytoactive compounds related to biological effects present in native southern Chilean plants: A review. J. Chil. Chem. Soc. 2025;69:6115–6128. doi: 10.4067/s0717-97072024000206115. [DOI] [Google Scholar]
  • 5.Francis J.K. Wildland S1hrubs of the United States and Its Territories. Volume 1. USDA; San Juan, PR, USA: 2004. [(accessed on 23 April 2025)]. pp. 542–544. Available online: https://www.fdacs.gov/Divisions-Offices/Florida-Forest-Service. [Google Scholar]
  • 6.Zardi-Bergaouia A., Jouinia M., Znatia M., El Ayeb-Zakhamab A., Janneta H.B. Physico-chemical properties, composition and antioxidant activity of seed oil from the Tunisian Virginia Creeper (Parthenocissus quinquefolia (L.) planch) J. Tunis. Chem. Soc. 2016;18:89–95. [Google Scholar]
  • 7.Khan Z., Faisal S., Anjum P., Sardar A.A., Siddiqui S.Z. Phytochemical properties and antioxidant activities of leaves and fruits extracts of Parthenocissus quinquefolia (L.) Planch. Bangladesh J. Bot. 2018;47:33–38. [Google Scholar]
  • 8.Frase D.M., Bannon S. Contact Dermatitis From Exposure to Virginia Creeper (Parthenocissus quinquefolia): A Deviation From the Saying “Leaves of Three, Let It Be”. Cureus. 2025;17:e86240. doi: 10.7759/cureus.86240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kumar S., Kunaparaju N., Zito S.W., Barletta M.A. Effect of Wrightia tinctoria and Parthenocissus quinquefolia on blood glucose and insulin levels in the Zucker diabetic rat model. J. Complement. Integr. Med. 2011;8:1. doi: 10.2202/1553-3840.1538. [DOI] [PubMed] [Google Scholar]
  • 10.Faisal S., Perveen A., Khan Z.U., Sardar A.A., Shaheen S., Manzoor A. Phytochemical screening and antioxidant potential of Parthenocissus quinquefolia (L.) planch extracts of bark and stem. Pak. J. Pharm. Sci. 2018;31:1813–1816. [PubMed] [Google Scholar]
  • 11.Cömert Önder F., Kalın S., Maraba Ö., Önder A., Ilgın P., Karabacak E. Anticancer, Antioxidant, Antimicrobial Activities, and HPLC Analysis of Alcoholic Extracts of Parthenocissus quinquefolia L. Plant Collected from Çanakkale. J. Adv. Res. Nat. Appl. Sci. 2024;10:116–133. doi: 10.28979/jarnas.1377901. [DOI] [Google Scholar]
  • 12.Theodoridis S., Drakou E.G., Hickler T., Thines M., Nogues-Bravo D. Evaluating natural medicinal resources and their exposure to global change. Lancet Planet Health. 2023;7:e155–e163. doi: 10.1016/S2542-5196(22)00317-5. [DOI] [PubMed] [Google Scholar]
  • 13.Pagare S., Bhatia M., Tripathi N., Pagare S., Bansal Y.K. Secondary metabolites of plants and their role: Overview. Curr. Trends Biotechnol. Pharm. 2015;9:293–304. [Google Scholar]
  • 14.Elshafie H.S., Camele I., Mohamed A.A. A Comprehensive Review on the Biological, Agricultural and Pharmaceutical Properties of Secondary Metabolites Based-Plant Origin. Int. J. Mol. Sci. 2023;24:3266. doi: 10.3390/ijms24043266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wawrosch C., Zotchev S.B. Production of bioactive plant secondary metabolites through in vitro technologies—Status and outlook. Appl. Microbiol. Biotechnol. 2021;105:6649–6668. doi: 10.1007/s00253-021-11539-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Li X., Li C., Zhang W., Wang Y., Qian P., Huang H. Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct. Target. Ther. 2023;8:239. doi: 10.1038/s41392-023-01502-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Marchi S., Guilbaud E., Tait S.W.G., Yamazaki T., Galluzzi L. Mitochondrial control of inflammation. Nat. Rev. Immunol. 2023;23:159–173. doi: 10.1038/s41577-022-00760-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhang H., Tsao R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr. Opin. Food Sci. 2016;8:33–42. doi: 10.1016/j.cofs.2016.02.002. [DOI] [Google Scholar]
  • 19.Griffiths K., Aggarwal B.B., Singh R.B., Buttar H.S., Wilson D., De Meester F. Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention. Diseases. 2016;4:28. doi: 10.3390/diseases4030028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Merecz-Sadowska A., Sadowski A., Zielińska-Bliźniewska H., Zajdel K., Zajdel R. Network Pharmacology as a Tool to Investigate the Antioxidant and Anti-Inflammatory Potential of Plant Secondary Metabolites-A Review and Perspectives. Int. J. Mol. Sci. 2025;26:6678. doi: 10.3390/ijms26146678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Muscolo A., Mariateresa O., Giulio T., Mariateresa R. Oxidative Stress: The Role of Antioxidant Phytochemicals in the Prevention and Treatment of Diseases. Int. J. Mol. Sci. 2024;25:3264. doi: 10.3390/ijms25063264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;29:372:n71. doi: 10.1136/bmj.n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Tanaka T., Linuma M., Murata H. Stilbene derivates in the stem of Parthenocissus quinquefolia. Phytochemistry. 1998;48:1045–1049. doi: 10.1016/S0031-9422(98)00071-5. [DOI] [Google Scholar]
  • 24.Yang J.B., Wang A.G., Ji T.F., Su Y.L. Two new oligostilbenes from the stem of Parthenocissus quinquefolia. J. Asian Nat. Prod. Res. 2014;16:275–280. doi: 10.1080/10286020.2013.877451. [DOI] [PubMed] [Google Scholar]
  • 25.Rattanata N., Sakda D., Suthep P., Wandee B., Bundit P., Ratree T., Phangthip U., Parcharee B., Jureerut D. Antioxidant and antibacterial properties of selected Thai weed extracts. Asian Pac. J. Trop. Biomed. 2014;4:890–895. doi: 10.12980/APJTB.4.2014APJTB-2014-0422. [DOI] [Google Scholar]
  • 26.Deshmukh-Omraj S. Preliminary phytochemical screening and antibacterial activity of Parthenocissus quinquefolia (L.) Planch. Int. J. Life Sci. 2017;8:68–71. [Google Scholar]
  • 27.Mohamed A.A., Salah M.M., El-Dein M.M.Z., EL-Hefny M., Ali H.M., Farraj D.A.A., Hatamleh A.A., Salem M.Z.M., Ashmawy N.A. Ecofriendly Bioagents, Parthenocissus quinquefolia, and Plectranthus neochilus Extracts to Control the Early Blight Pathogen (Alternaria solani) in Tomato. Agronomy. 2021;11:911. doi: 10.3390/agronomy11050911. [DOI] [Google Scholar]
  • 28.Ben Ticha M., Meksi N., Attia H.E., Haddar W., Guesmi A., Ben Jannet H., Mhenni M.F. Ultrasonic extraction of Parthenocissus quinquefolia colorants: Extract identification by HPLC-MS analysis and cleaner application on the phytodyeing of natural fibres. Dye. Pigment. 2017;141:103–111. doi: 10.1016/j.dyepig.2017.02.002. [DOI] [Google Scholar]
  • 29.Makhynia L., Yemelianova O. Anatomical and phytochemical study leaves of Parthenocissus quinquefolia (L.) Planch. Phytother. J. 2023;3:108–112. doi: 10.32782/2522-9680-2023-3-108. [DOI] [Google Scholar]
  • 30.Konovalova O., Yashchuk B., Hurtovenko I., Shcherbakova O., Kalista M., Sydora N. Study on content of flavonoids and antioxidant activity of the raw materials of Parthenocissus quinquefolia (L.) Planch. Sci. Pharm. Sci. 2023;6:87–95. doi: 10.15587/2519-4852.2023.295506. [DOI] [Google Scholar]
  • 31.Rónavári A., Balázs M., Szilágyi Á., Molnár C., Kotormán M., Ilisz I., Kiricsi M., Kónya Z. Multi-round recycling of green waste for the production of iron nanoparticles: Synthesis, characterization, and prospects in remediation. Discov. Nano. 2023;18:8. doi: 10.1186/s11671-023-03784-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fang X., Yang C.Q., Wei Y.K., Ma Q.X., Yang L., Chen X.Y. Genomics grand for diversified plant secondary metabolites. Plant Div. Res. 2011;33:53–64. [Google Scholar]
  • 33.Verpoorte R., Alfermann A.W. Metabolic Engineering of Plant Secondary Metabolism. Kluwer Academic Publishers; Dordrecht, The Netherlands: 2000. [(accessed on 23 April 2025)]. pp. 1–23. Available online: https://www.uv.mx/personal/tcarmona/files/2019/02/Verpoorte-y-Alfermann-2000.pdf. [Google Scholar]
  • 34.Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010;2:1231–1246. doi: 10.3390/nu2121231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Albuquerque B.R., Heleno S.A., Oliveira M.B., Barros L., Ferreira I.C. Phenolic compounds: Current industrial aplications, limitations and future challenges. Food Funct. 2021;12:14–29. doi: 10.1039/D0FO02324H. [DOI] [PubMed] [Google Scholar]
  • 36.Bruneton J. Farmacognosia: Fitoquímica y Plantas Medicinales. 2nd ed. Editorial ACRIBIA; Madrid, España: 1993. [(accessed on 25 April 2025)]. pp. 305–341. Available online: https://tejadarossi.wordpress.com/wp-content/uploads/2017/01/farmacognosia_bruneton.pdf. [Google Scholar]
  • 37.Lim I., Ha J. Biosynthetic Pathway of Proanthocyanidins in Major Cash Crops. Plants. 2021;10:1792. doi: 10.3390/plants10091792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:e47. doi: 10.1017/jns.2016.41. Erratum in J. Nutr. Sci. 2025, 14, e11. https://doi.org/10.1017/jns.2024.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Westerterp-Plantenga M.S. Green tea catechins, caffeine and body-weight regulation. Physiol. Behav. 2010;100:42–46. doi: 10.1016/j.physbeh.2010.02.005. [DOI] [PubMed] [Google Scholar]
  • 40.Jin J.S., Touyama M., Hisada T., Benno Y. Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiol. Immunol. 2012;56:729–739. doi: 10.1111/j.1348-0421.2012.00502.x. [DOI] [PubMed] [Google Scholar]
  • 41.Marais J.P.J., Deavours B., Dixon R.A., Ferreira D. The Stereochemistry of Flavonoids. In: Grotewold E., editor. The Science of Flavonoids. Springer; New York, NY, USA: 2006. [(accessed on 25 April 2025)]. pp. 1–46. Available online: https://link.springer.com/chapter/10.1007/978-0-387-28822-2_1. [Google Scholar]
  • 42.Anitha S., Krishnan S., Senthilkumar K., Sasirekha V. Theoretical investigation on the structure and antioxidant activity of (+) catechin and (−) epicatechin—A comparative study. Mol. Phys. 2020;118:e1745917. doi: 10.1080/00268976.2020.1745917. [DOI] [Google Scholar]
  • 43.Shay J., Elbaz H.A., Lee I., Zielske S.P., Malek M.H., Hüttemann M. Mechanism and Therapeutic Effects of (-) Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration. Oxidative Med. Cell. Longev. 2015;2015:181260. doi: 10.1155/2015/181260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ramirez-Sanchez I., Maya L., Ceballos G., Villarreal F. (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension. 2010;55:1398–1405. doi: 10.1161/HYPERTENSIONAHA.109.147892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wu C., Suzuki K. The Effects of Flavonoids on Skeletal Muscle Mass, Muscle Function, and Physical Performance in Individuals with Sarcopenia: A Systematic Review of Randomized Controlled Trials. Nutrients. 2023;15:3897. doi: 10.3390/nu15183897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Yang D.J., Liu S.C., Chen Y.C., Hsu S.H., Chang Y.P., Lin J.T. Three Pathways Assess Anti-Inflammatory Response of Epicatechin with Lipopolysaccharide-Mediated Macrophage RAW264.7 Cells. J. Food Biochem. 2015;39:334–343. doi: 10.1111/jfbc.12134. [DOI] [Google Scholar]
  • 47.Vazquez-Prieto M.A., Bettaieb A., Haj F.G., Fraga C.G., Oteiza P.I. (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 2012;527:113–118. doi: 10.1016/j.abb.2012.02.019. Erratum in Arch. Biochem. Biophys. 2024, 756, 109992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Schroeter H., Heiss C., Balzer J., Kleinbongard P., Keen C.L., Hollenberg N.K., Sies H., Kwik-Uribe C., Schmitz H.H., Kelm M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA. 2006;103:1024–1029. doi: 10.1073/pnas.0510168103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Morrison M., van der Heijden R., Heeringa P., Kaijzel E., Verschuren L., Blomhoff R., Kooistra T., Kleemann R. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis. 2014;233:149–156. doi: 10.1016/j.atherosclerosis.2013.12.027. [DOI] [PubMed] [Google Scholar]
  • 50.Nakagawa K., Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J. Nutr. Sci. Vitaminol. 1997;43:679–684. doi: 10.3177/jnsv.43.679. [DOI] [PubMed] [Google Scholar]
  • 51.Frei B., Higdon J.V. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr. 2003;133:3275S–3284S. doi: 10.1093/jn/133.10.3275S. [DOI] [PubMed] [Google Scholar]
  • 52.Ahmed S., Pakozdi A., Koch A.E. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2006;54:2393–2401. doi: 10.1002/art.22023. [DOI] [PubMed] [Google Scholar]
  • 53.Lee H.E., Yang G., Park Y.B., Kang H.C., Cho Y.Y., Lee H.S., Lee J.Y. Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis. Molecules. 2019;24:2138. doi: 10.3390/molecules24112138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Gerges Geagea A., Rizzo M., Eid A., Hajj Hussein I., Zgheib Z., Zeenny M.N., Jurjus R., Uzzo M.L., Spatola G.F., Bonaventura G., et al. Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis. J. Biol. Regul. Homeost. Agents. 2017;31:865–877. [PubMed] [Google Scholar]
  • 55.Chen G., Cheng K., Niu Y., Zhu L., Wang X. (-)-Epicatechin gallate prevents inflammatory response in hypoxia-activated microglia and cerebral edema by inhibiting NF-κB signaling. Arch. Biochem. Biophys. 2022;729:109393. doi: 10.1016/j.abb.2022.109393. [DOI] [PubMed] [Google Scholar]
  • 56.Wang H., Cao Z.-R. Anti-inflammatory Effects of (-)-Epicatechin in Lipopolysaccharide-Stimulated Raw 264.7 Macrophages. Trop. J. Pharm. Res. 2014;13:1415–1419. doi: 10.4314/tjpr.v13i9.6. [DOI] [Google Scholar]
  • 57.Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 2008;585:325–337. doi: 10.1016/j.ejphar.2008.03.008. [DOI] [PubMed] [Google Scholar]
  • 58.Mirza M.A., Mahmood S., Hilles A.R., Ali A., Khan M.Z., Zaidi S.A.A., Iqbal Z., Ge Y. Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review. Pharmaceuticals. 2023;16:1631. doi: 10.3390/ph16111631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Jazvinšćak Jembrek M., Oršolić N., Mandić L., Sadžak A., Šegota S. Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration. Antioxidants. 2021;10:1628. doi: 10.3390/antiox10101628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Cheng S.C., Huang W.C.S., Pang J.H., Wu Y.H., Cheng C.Y. Quercetin Inhibits the Production of IL-1β-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-κB Signaling Pathways. Int. J. Mol. Sci. 2019;20:2957. doi: 10.3390/ijms20122957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Carrillo-Martinez E.J., Flores-Hernández F.Y., Salazar-Montes A.M., Nario-Chaidez H.F., Hernández-Ortega L.D. Quercetin, a Flavonoid with Great Pharmacological Capacity. Molecules. 2024;29:1000. doi: 10.3390/molecules29051000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Lee E.H., Park H.J., Jung H.Y., Kang I.K., Kim B.O., Cho Y.J. Isoquercitrin isolated from newly bred Green ball apple peel in lipopolysaccharide-stimulated macrophage regulates NF-κB inflammatory pathways and cytokines. 3 Biotech. 2022;12:100. doi: 10.1007/s13205-022-03118-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Ma J., Li M., Yang T., Deng Y., Ding Y., Guo T., Shang J. Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90. Int. J. Mol. Sci. 2023;24:8795. doi: 10.3390/ijms24108795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Gullón B., Lú-Chau T.A., Moreira M.T., Lema J.M., Eibes G. Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability. Trends Food Sci. Technol. 2017;67:220–235. doi: 10.1016/j.tifs.2017.07.008. [DOI] [Google Scholar]
  • 65.Tian C., Liu X., Chang Y., Wang R., Yang M., Liu M. Rutin prevents inflammation induced by lipopolysaccharide in RAW 264.7 cells via conquering the TLR4-MyD88-TRAF6-NF-κB signalling pathway. J. Pharm. Pharmacol. 2021;73:110–117. doi: 10.1093/jpp/rgaa015. [DOI] [PubMed] [Google Scholar]
  • 66.Yeh C.H., Yang J.J., Yang M.L., Li Y.C., Kuan Y.H. Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway. Free. Radic. Biol. Med. 2014;69:249–257. doi: 10.1016/j.freeradbiomed.2014.01.028. [DOI] [PubMed] [Google Scholar]
  • 67.Wu J., Maoqiang L., Fan H., Zhenyu B., Qifang H., Xuepeng W., Liulong Z. Rutin attenuates neuroinflammation in spinal cord injury rats. J. Surg. Res. 2016;203:331–337. doi: 10.1016/j.jss.2016.02.041. [DOI] [PubMed] [Google Scholar]
  • 68.Guardia T., Rotelli A.E., Juarez A.O., Pelzer L.E. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco. 2001;56:683–687. doi: 10.1016/S0014-827X(01)01111-9. [DOI] [PubMed] [Google Scholar]
  • 69.Semwal D.K., Semwal R.B., Combrinck S., Viljoen A. Myricetin: A Dietary Molecule with Diverse Biological Activities. Nutrients. 2016;8:90. doi: 10.3390/nu8020090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships. Free. Radic. Biol. Med. 1997;22:749–760. doi: 10.1016/S0891-5849(96)00351-6. [DOI] [PubMed] [Google Scholar]
  • 71.Chen T., Hu Y., Lu L., Zhao Q., Tao X., Ding B., Chen S., Zhu J., Guo X., Lin Z. Myricetin attenuates hypoxic-ischemic brain damage in neonatal rats via NRF2 signaling pathway. Front. Pharmacol. 2023;14:1134464. doi: 10.3389/fphar.2023.1134464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Imran M., Saeed F., Hussain G., Imran A., Mehmood Z., Gondal T.A., El-Ghorab A., Ahmad I., Pezzani R., Arshad M.U., et al. Myricetin: A comprehensive review on its biological potentials. Food Sci. Nutr. 2021;9:5854–5868. doi: 10.1002/fsn3.2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Stabrauskiene J., Kopustinskiene D.M., Lazauskas R., Bernatoniene J. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities. Biomedicines. 2022;10:1686. doi: 10.3390/biomedicines10071686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Jiang H., Zhang M., Lin X., Zheng X., Qi H., Chen J., Zeng X., Bai W., Xiao G. Biological Activities and Solubilization Methodologies of Naringin. Foods. 2023;12:2327. doi: 10.3390/foods12122327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Bharti S., Rani N., Krishnamurthy B., Arya D.S. Preclinical evidence for the pharmacological actions of naringin: A review. Planta Medica. 2014;80:437–451. doi: 10.1055/s-0034-1368351. [DOI] [PubMed] [Google Scholar]
  • 76.Kumar R.P., Abraham A. Inhibition of LPS induced pro-inflammatory responses in RAW 264.7 macrophage cells by PVP-coated naringenin nanoparticle via down regulation of NF-κB/P38MAPK mediated stress signaling. Pharmacol. Rep. 2017;69:908–915. doi: 10.1016/j.pharep.2017.04.002. [DOI] [PubMed] [Google Scholar]
  • 77.Kanno S., Tomizawa A., Ohtake T., Koiwai K., Ujibe M., Ishikawa M. Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol. Lett. 2006;166:131–139. doi: 10.1016/j.toxlet.2006.06.005. [DOI] [PubMed] [Google Scholar]
  • 78.Liu X., Liu M., Mo Y., Peng H., Gong J., Li Z., Chen J., Xie J. Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats. Iran. J. Basic Med. Sci. 2016;19:417–422. [PMC free article] [PubMed] [Google Scholar]
  • 79.Jeon S.M., Bok S.H., Jang M.K., Lee M.K., Nam K.T., Park Y.B., Rhee S.J., Choi M.S. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci. 2001;69:2855–2866. doi: 10.1016/S0024-3205(01)01363-7. [DOI] [PubMed] [Google Scholar]
  • 80.López-Lázaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 2009;9:31–59. doi: 10.2174/138955709787001712. [DOI] [PubMed] [Google Scholar]
  • 81.Vlocskó R.B., Mastyugin M., Török B., Török M. Correlation of physicochemical properties with antioxidant activity in phenol and thiophenol analogues. Sci. Rep. 2025;15:73. doi: 10.1038/s41598-024-83982-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Rolt A., Cox L.S. Structural basis of the anti-ageing effects of polyphenolics: Mitigation of oxidative stress. BMC Chem. 2020;14:50. doi: 10.1186/s13065-020-00696-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Lin Y., Shi R., Wang X., Shen H.M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets. 2008;8:634–646. doi: 10.2174/156800908786241050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Chen C.Y., Peng W.H., Tsai K.D., Hsu S.L. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 2007;81:1602–1614. doi: 10.1016/j.lfs.2007.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Lee M.N., Lee Y., Wu D., Pae M. Luteolin inhibits NLRP3 inflammasome activation via blocking ASC oligomerization. J. Nutr. Biochem. 2021;92:108614. doi: 10.1016/j.jnutbio.2021.108614. [DOI] [PubMed] [Google Scholar]
  • 86.Jang S., Kelley K.W., Johnson R.W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. USA. 2008;105:7534–7539. doi: 10.1073/pnas.0802865105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Pandurangan A.K., Dharmalingam P., Sadagopan S.K., Ganapasam S. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Hum. Exp. Toxicol. 2014;33:1176–1185. doi: 10.1177/0960327114522502. [DOI] [PubMed] [Google Scholar]
  • 88.Sepehri S., Khedmati M., Yousef-Nejad F., Mahdavi M. Medicinal chemistry perspective on the structure-activity relationship of stilbene derivatives. RSC Adv. 2024;14:19823–19879. doi: 10.1039/D4RA02867H. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Su X., Zhou D., Li N. Bioactive stilbenes from plants. Stud. Nat. Prod. Chem. 2022;73:265–403. [Google Scholar]
  • 90.Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006;5:493–506. doi: 10.1038/nrd2060. [DOI] [PubMed] [Google Scholar]
  • 91.Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 2000;164:6509–6519. doi: 10.4049/jimmunol.164.12.6509. [DOI] [PubMed] [Google Scholar]
  • 92.Kundu J.K., Surh Y.J. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res. 2004;555:65–80. doi: 10.1016/j.mrfmmm.2004.05.019. [DOI] [PubMed] [Google Scholar]
  • 93.Kundu J.K., Shin Y.K., Kim S.H., Surh Y.J. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis. 2006;27:1465–1474. doi: 10.1093/carcin/bgi349. [DOI] [PubMed] [Google Scholar]
  • 94.Sarubbo F., Esteban S., Miralles A., Moranta D. Effects of Resveratrol and other Polyphenols on Sirt1: Relevance to Brain Function During Aging. Curr. Neuropharmacol. 2018;16:126–136. doi: 10.2174/1570159X15666170703113212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Csiszar A., Labinskyy N., Podlutsky A., Kaminski P.M., Wolin M.S., Zhang C., Mukhopadhyay P., Pacher P., Hu F., de Cabo R., et al. Vasoprotective effects of resveratrol and SIRT1: Attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol.-Heart Circ. Physiol. 2008;294:H2721–H2735. doi: 10.1152/ajpheart.00235.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.He S., Jiang L., Wu B., Zhou J., Pan Y.J. Two Novel Antioxidative Stilbene Tetramers from Parthenocissus laetevirens. Helv. Chim. Acta. 2009;92:1260–1267. doi: 10.1002/hlca.200800371. [DOI] [Google Scholar]
  • 97.Lin M., Yao C.S. Natural Oligostilbenes. Stud. Nat. Prod. Chem. 2006;33:601–644. [Google Scholar]
  • 98.He S., Wu B., Pan Y., Jiang L. Stilbene oligomers from Parthenocissus laetevirens: Isolation, biomimetic synthesis, absolute configuration, and implication of antioxidative defense system in the plant. J. Org. Chem. 2008;73:5233–5241. doi: 10.1021/jo8001112. [DOI] [PubMed] [Google Scholar]
  • 99.He S., Yang J., Wu B., Pan Y., Wan H., Wang Y., Du Y., Wang S. Neuroprotective effect of parthenocissin A, a natural antioxidant and free radical scavenger, in focal cerebral ischemia of rats. Phytother. Res. 2010;24:S63–S70. doi: 10.1002/ptr.2904. Erratum in Phytother. Res. 2010, 24, 632. [DOI] [PubMed] [Google Scholar]
  • 100.Li C., Xu X., Tao Z., Wang X.J., Pan Y. Resveratrol dimers, nutritional components in grape wine, are selective ROS scavengers and weak Nrf2 activators. Food Chem. 2015;173:218–223. doi: 10.1016/j.foodchem.2014.09.165. [DOI] [PubMed] [Google Scholar]
  • 101.Danışman B., Ercan Kelek S., Aslan M. Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria. Psychiatry Clin. Psychopharmacol. 2023;33:147–155. doi: 10.5152/pcp.2023.23633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Gomes B.A.Q., Silva J.P.B., Romeiro C.F.R., Dos Santos S.M., Rodrigues C.A., Gonçalves P.R., Sakai J.T., Mendes P.F.S., Varela E.L.P., Monteiro M.C. Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1. Oxidative Med. Cell. Longev. 2018;2018:8152373. doi: 10.1155/2018/8152373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Beaumont P., Courtois A., Atgié C., Richard T., Krisa S. In the shadow of resveratrol: Biological activities of epsilon-viniferin. J. Physiol. Biochem. 2022;78:465–484. doi: 10.1007/s13105-022-00880-x. Erratum in J. Physiol. Biochem. 2022, 78, 933. [DOI] [PubMed] [Google Scholar]
  • 104.Fuloria S., Sekar M., Khattulanuar F.S., Gan S.H., Rani N.N.I.M., Ravi S., Subramaniyan V., Jeyabalan S., Begum M.Y., Chidam-baram K., et al. Chemistry, Biosynthesis and Pharmacology of Viniferin: Potential Resveratrol-Derived Molecules for New Drug Discovery, Devel-opment and Therapy. Molecules. 2022;27:5072. doi: 10.3390/molecules27165072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Billard C., Izard J.C., Roman V., Kern C., Mathiot C., Mentz F., Kolb J.P. Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk. Lymphoma. 2002;43:1991–2002. doi: 10.1080/1042819021000015952. [DOI] [PubMed] [Google Scholar]
  • 106.Whitlock N.C., Baek S.J. The anticancer effects of resveratrol: Modulation of transcription factors. Nutr. Cancer. 2012;64:493–502. doi: 10.1080/01635581.2012.667862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Burdge G.C., Calder P.C. Introduction to fatty acids and lipids. World Rev. Nutr. Diet. 2015;112:1–16. doi: 10.1159/000365423. [DOI] [PubMed] [Google Scholar]
  • 108.Ku K.T., Huang Y.L., Huang Y.J., Chiou W.F. Miyabenol A inhibits LPS-induced NO production via IKK/IkappaB inactivation in RAW 264.7 macrophages: Possible involvement of the p38 and PI3K pathways. J. Agric. Food Chem. 2008;56:8911–8918. doi: 10.1021/jf8019369. [DOI] [PubMed] [Google Scholar]
  • 109.Wallis C.M. Microplate bioassay to examine the effects of grapevine-isolated stilbenoids on survival of root knot nema-todes. BMC Res. Notes. 2022;15:220. doi: 10.1186/s13104-022-06106-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Morvaridzadeh M., Estêvão M.D., Morvaridi M., Belančić A., Mohammadi S., Hassani M., Heshmati J., Ziaei S. The effect of Conjugated Linoleic Acid intake on oxidative stress parameters and antioxidant enzymes: A systematic review and meta-analysis of randomized clinical trials. Prostaglandins Other Lipid Mediat. 2022;163:106666. doi: 10.1016/j.prostaglandins.2022.106666. [DOI] [PubMed] [Google Scholar]
  • 111.Kim Y., Kim J., Whang K.Y., Park Y. Impact of Conjugated Linoleic Acid (CLA) on Skeletal Muscle Metabolism. Lipids. 2016;51:159–178. doi: 10.1007/s11745-015-4115-8. [DOI] [PubMed] [Google Scholar]
  • 112.Innes J.K., Calder P.C. Omega-6 fatty acids and inflammation. Prostaglandins Leukot. Essent. Fat. Acids. 2018;132:41–48. doi: 10.1016/j.plefa.2018.03.004. [DOI] [PubMed] [Google Scholar]
  • 113.Green C.D., Maceyka M., Cowart L.A., Spiegel S. Sphingolipids in metabolic disease: The good, the bad, and the unknown. Cell Metab. 2021;33:1293–1306. doi: 10.1016/j.cmet.2021.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Petersen M.C., Shulman G.I. Mechanisms of Insulin Action and Insulin Resistance. Physiol. Rev. 2018;98:2133–2223. doi: 10.1152/physrev.00063.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Wang P., Ni M., Tian Y., Wang H., Qiu J., You W., Wei S., Shi Y., Zhou J., Cheng F., et al. Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling. iScience. 2021;24:102427. doi: 10.1016/j.isci.2021.102427. Erratum in iScience 2021, 24, 103335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Abu-Halaka D., Shpaizer A., Zeigerman H., Kanner J., Tirosh O. DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine. Antioxidants. 2023;12:512. doi: 10.3390/antiox12020512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Wang N., Li J.Y., Zeng B., Chen G.L. Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases. Biomolecules. 2023;13:818. doi: 10.3390/biom13050818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Soto-Alarcon S.A., Valenzuela R., Valenzuela A., Videla L.A. Liver Protective Effects of Extra Virgin Olive Oil: Interaction between Its Chemical Composition and the Cell-signaling Pathways Involved in Protection. Endocr. Metab. Immune Disord.-Drug Targets. 2018;18:75–84. doi: 10.2174/1871530317666171114120552. [DOI] [PubMed] [Google Scholar]
  • 119.Boronat A., Serreli G., Rodríguez-Morató J., Deiana M., de la Torre R. Olive Oil Phenolic Compounds’ Activity against Age-Associated Cognitive Decline: Clinical and Experimental Evidence. Antioxidants. 2023;12:1472. doi: 10.3390/antiox12071472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Tutunchi H., Ostadrahimi A., Saghafi-Asl M. The Effects of Diets Enriched in Monounsaturated Oleic Acid on the Management and Prevention of Obesity: A Systematic Review of Human Intervention Studies. Adv. Nutr. 2020;11:864–877. doi: 10.1093/advances/nmaa013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Yang J., Wang A., Ji T., Su Y. Chemical constituents from Parthenocissus quinquefolia. Zhongguo Zhong Yao Za Zhi. 2010;35:1573–1576. doi: 10.4268/cjcmm20101215. (In Chinese) [DOI] [PubMed] [Google Scholar]
  • 122.Keylor M.H., Matsuura B.S., Stephenson C.R. Chemistry and Biology of Resveratrol-Derived Natural Products. Chem. Rev. 2015;115:8976–9027. doi: 10.1021/cr500689b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Ha D.T., Long P.T., Hien T.T., Tuan D.T., An N.T.T., Khoi N.M., Van Oanh H., Hung T.M. Anti-inflammatory effect of oligostilbenoids from Vitis heyneana in LPS-stimulated RAW 264.7 macrophages via suppressing the NF-κB activation. Chem. Cent. J. 2018;12:14. doi: 10.1186/s13065-018-0386-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Waffo-Téguo P., Shaver J., Mérilon J.M. Stilbenoid chemistry from wine and the genus Vitis, a review. OENO One. 2012;46:57–111. doi: 10.20870/oeno-one.2012.46.2.1512. [DOI] [Google Scholar]
  • 125.Papastamoulis Y., Bisson J., Temsamani H., Richard T., Marchal A., Mérillon J.M., Waffo-Téguo P. New E-miyabenol isomer isolated from grapevine cane using centrifugal partition chromatography guided by mass spectrometry. Tetrahedron. 2015;71:3138–3142. doi: 10.1016/j.tet.2014.08.029. [DOI] [Google Scholar]
  • 126.Hu J., Lin T., Gao Y., Xu J., Jiang C., Wang G., Bu G., Xu H., Chen H., Zhang Y.W. The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation. PLoS ONE. 2015;10:e0115973. doi: 10.1371/journal.pone.0115973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Li Y., Yao J., Han C., Yang J., Chaudhry M.T., Wang S., Liu H., Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016;8:167. doi: 10.3390/nu8030167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Sheng Y., Sun Y., Tang Y., Yu Y., Wang J., Zheng F., Li Y., Sun Y. Catechins: Protective mechanism of antioxidant stress in atherosclerosis. Front. Pharmacol. 2023;14:1144878. doi: 10.3389/fphar.2023.1144878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Saleem M., Kim H.J., Jin C., Lee Y.S. Antioxidant caffeic acid derivatives from leaves of Parthenocissus tricuspidata. Arch. Pharmacal Res. 2004;27:300–304. doi: 10.1007/BF02980064. [DOI] [PubMed] [Google Scholar]
  • 130.Calderón-Montaño J.M., Burgos-Morón E., Pérez-Guerrero C., López-Lázaro M. A review on the dietary flavonoid kaempferol. Mini Rev. Med. Chem. 2011;11:298–344. doi: 10.2174/138955711795305335. [DOI] [PubMed] [Google Scholar]
  • 131.Yang X., Deng W. Review on the adhesive tendrils of Parthenocissus. Chin. Sci. Bull. 2014;59:113–124. doi: 10.1007/s11434-013-0037-0. [DOI] [Google Scholar]
  • 132.Shah J.J., Dave Y.S. Morpho-Histogenic Studies on Tndrild of Vitaceae. Am. J. Bot. 1970;57:363–373. [Google Scholar]
  • 133.Bowling A.J., Vaughn K.C. Structural and immunocytochemical characterization of the adhesive tendril of Virginia creeper (Parthenocissus quinquefolia [L.] Planch.) Protoplasma. 2008;232:153–163. doi: 10.1007/s00709-008-0287-x. [DOI] [PubMed] [Google Scholar]
  • 134.Hurrell J.A., Delucchi G., Cabanillas P. Primera cita de Parthenocissus tricuspidata y nuevo registro de P. quinquefolia (Vitaceae) adventicias en la Argentina. Rev. Mus. Argent. Cienc. Nat. 2012;14:235–242. doi: 10.22179/REVMACN.14.195. [DOI] [Google Scholar]
  • 135.Khamineh Y., Ghiasvand M., Panahi-Alanagh S., Rastegarmand P., Zolghadri S., Stanek A. A Narrative Review of Quercetin’s Role as a Bioactive Compound in Female Reproductive Disorders. Nutrients. 2025;17:1118. doi: 10.3390/nu17071118. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

No new data were created or analyzed in this study. Data sharing does not apply to this article.


Articles from Antioxidants are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES